期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

视神经脊髓炎与水通道蛋白4抗体及其检测方法的研究进展 被引量：2

Relation of neuromyelitis optica with aquaporin-4 antibody and its detection method： an update
原文传递
导出
摘要 视神经脊髓炎（neuromyelitis optica,NMO）是一种严重的、突发性的中枢神经系统炎性脱髓鞘性的自身免疫性疾病,主要累及视神经和脊髓[1].1884年Eugène Devic报道1例45岁法国妇女呈亚急性发病的视力障碍和双下肢瘫痪、尿潴留,后经尸检证实为累及视神经和胸腰段脊髓的严重脱髓鞘和坏死,称之为NMO[2].随着NMO病例报道的增多以及相关研究的进展,人们发现NMO和部分多发性硬化（multiple sclerosis,MS）的临床表现相似.
作者 李世容 楚兰
机构地区 贵阳市第一人民医院神经科 贵阳医学院附属医院神经科
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2011年第1期97-99,共3页 Chinese Journal of Neuromedicine
关键词 视神经脊髓炎 水通道蛋白4抗体 Neuromyelitis Optica Aquaporin-4 antibody
分类号 R744.52 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献26

  • 1Wingerchuk DM,Lennon VA,Lucchinetti CF,et al.The spectrum of neuromyelitis optica[J].Lancet Neurol,2007,6(9):805-815.
  • 2吴卫平.关注视神经脊髓炎的特殊性[J].中华神经科杂志,2009,42(6):361-364. 被引量：10
  • 3Lennon VA,Kryzer TJ,Pittock SJ,et al.IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel[J].J Exp Med,2005,202(4):473-477.
  • 4Wingerchuk DM.Neuromyelitis optica[J] ,Int MS J,2006,13(2):42-50.
  • 5Lennon VA,Wingerchuk DM,Kryzer TJ,et al.A serum autoantibody marker of neuromyelitis optica:distinction from multiple sclerosis[J].Lancet,2004,364(9451):2106-2112.
  • 6Pittock SJ,Weinshenker BG,Lucchinetti CF,et al.Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression[J].Arch Neurol,2006,63(7):964-968.
  • 7Ito S,Mori M,Makino T,et al."Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica[J].Ann Neurol,2009,66(3):425-428.
  • 8陈道文,徐俊,刘文,王凌玲,狄晴.视神经脊髓炎脑部病灶的影像学特征及临床表现[J].中华神经医学杂志,2009,8(8):825-827. 被引量：9
  • 9戚晓昆.视神经脊髓炎的诊断与治疗[J].中国全科医学,2007,10(12):955-956. 被引量：8
  • 10Venero JL,Vizuete ML,Machado A,et al.Aquaporins in the central nervous system[J].Prog Neurobiol,2001,63(3):321-336.

二级参考文献31

  • 1李海峰,丛志强.合并多发性硬化或视神经炎的重症肌无力临床分析[J].中华神经科杂志,2005,38(4):261-264. 被引量：6
  • 2Nakamura M,Miyazawa I,Fujihara K,et al.Preferential spinal central gray matter involvement in neuromyelitis optica.J Neurol,2008,255:163-170.
  • 3Pittock SJ,Lemmn VA,Krecke K,et al.Brain abnormalities in neuromyelitis optica.Arch Ncurul,2006,63:390-396.
  • 4Pittock SJ,Weinshenker BG,Lucchinetti CF,et al.Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.Arch Neurol,2006,63:964-968.
  • 5Cabrera-Gomez JA,Quevedo-Sotolongo L,Gonzalez-Quevedo A,et al.Brain magnetic resonance imaging findings in relapsing neuromyelitis optica.Mult Scler,2007,13:186-192.
  • 6Wingerchuk DM,Weinshenker BG.Neuromyelitis optica.Curr Treat Options Neuml,2008,10:55456.
  • 7Matiello M,Lennon VA,Jacob A,et al.NMO-IgG predicts the outcome of recurrent optic neuritis.Neurology,2008,70:2197-2200.
  • 8Wingerchuk DM,Lennon VA,Pittock SJ,et al.Revised diagnostic criteria for neuromyelitis optica.Neurology,2006,66:1485-1489.
  • 9Papeix C,Vidal JS,de Seze J.Immunosuppressive therapy is more effective than interferon in neuromyelitis optica.Mult Scler,2007,13:256-259.
  • 10Lennon VA,Wingerchuk DM,Kryzer TJ,et al.A serum autoantibody marker of neuromyelitis optics:distinction from multiple sclerosis.Lancet,2004,364:2106-2112.

共引文献28

同被引文献31

  • 1Lennon VA, Wingerchuk DM, Kryzer T J, et al. A serum antibody marker of neuromyelitis optica: distinction from multiple sclerosis [J]. Lancet, 2004, 364(9451): 2106-2112.
  • 2Wingerchuk DM, Lennon VA, Pittock S J, et al. The spectrum of neuromyelitis optica[J]. Lancet Neurol, 2007, 6(9): 805-815.
  • 3Takahashi T, Fujihara K, Nakashima I, et al. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica [J]. Tohoku J Exp Med, 2006, 210 (4): 307-313.
  • 4Takahashi T, FUjihara K, Nakashima I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre[J]. Brain, 2007, 130(Pt 5): 1235-1243.
  • 5Waters P, Jarius S, Vincent A, et al. Aquaporin-4 antibodies in neurnmyelitis optica and longitudinally extensive transverse myelitis[J]. Arch Neurol, 2008, 65(7): 913-919.
  • 6Wingerchuk DM. Diagnosis and treatment of neuromyelitis optica [J]. Neurologist, 2007, 13(1): 2-11.
  • 7Polman CH, Reingold SC, Edan G, et al. diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald criteria. Ann Neurol, 2005, 58(6): 840-846.
  • 8Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded disability status scale (EDSS)[J]. Neurology, 1983, 33 (1 1): 1444-1452.
  • 9Jarius S, Wildemann B. AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance[J]. Nat Rev Neurol, 2010, 6 (7): 383-392.
  • 10Lennon VA, Kryzer T J, Pittock S J, et al. lgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel[J]. J Exp Med, 2005, 202(4): 473-477.

引证文献2

二级引证文献16

中华神经医学杂志
2011年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部